Navigation Links
GenScript Announces Joint Road Show with Open Monoclonal Technology, Inc.
Date:1/22/2013

PISCATAWAY, N.J., Jan. 22, 2013 /PRNewswire/ -- GenScript and Open Monoclonal Technology, Inc. (OMT) today announced a joint road show with potential clients across the US, China, Japan and South Korea in late January and early February. The road show will offer prospective clients introductions to GenScript and OMT's human antibody discovery technologies and explore new ways of accelerated and improved development of this important class of human therapeutics.

GenScript

GenScript offers a full spectrum of human antibody services, including target screening and expression, immunization, monoclonal antibody screening at any desired high complexity, antibody sequencing and characterization, biological and other assays, antibody production cell line development, model animal-based efficacy studies and more. GenScript's antibody development team consists of senior scientists and business managers who have extensive experience in therapeutic antibody development. They have been involved in the full process of therapeutic drug development. GenScript has already successfully gained a top position in gene synthesis worldwide, and has established leading positions in many other biology service areas.

Open Monoclonal Technology, Inc.

Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for the development of human therapeutic antibodies – naturally optimized human antibodies™. OMT has created OmniRat™, the first fully human monoclonal antibody platform based on transgenic rats. OmniRat™ uses an improved understanding of B cell development and a new approach to inactivation of endogenous antibody expression, which enables them to make antibodies with human idiotypes as efficiently as wild type rats make normal antibodies. OmniRat™ represents a novel and proprietary technology
'/>"/>

SOURCE GenScript USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GenScript anuncia un programa conjunto con Open Monoclonal Technology, Inc.
2. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
3. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
4. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
5. TNI BioTech, Inc. Announces Appointment of New CFO
6. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
7. BioDelivery Sciences Announces Completion of BNX Safety Study
8. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
9. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
10. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
11. Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and approved all parts required to build nine ... to manufacture the new PCT-based instrument system.  The ... for shipment by mid-October and that additional Barozyme ... rate of about one per week thereafter.  ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking ... is re-visiting that advice and changing his stance after ... wine have on oral health. “There’s good news and great ... be beneficial in protecting against gum disease, and red wine ... coffee was from the September 2014 issue of Boston ...
(Date:9/20/2014)... Earlier this week, Home Depot revealed that up to ... card information pilfered by hackers, surpassing the 40 million Target ... articles like this one published by Bloomberg on September ... , “Most people tend to focus on how many credit ... score a game,” says Joe Caruso, founder and CEO/CTO of ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Arizona ... College (MCC) is celebrating National Manufacturing Day by opening ... enhanced machining, processing and additive manufacturing labs will be ... 3, 2014 at MCC’s Southern and Dobson campus (1833 ... in southeast Lot D. , The AzAMI at MCC ...
(Date:9/20/2014)... The children of Branches now have a new ... need. An empty lot at the Trish and Dan ... into a kid-designed playspace in less than eight hours ... ESPN (@TeamESPN), Disney (@CitizenDisney), area residents and organizers from ... more than a playground. It’s a brain-expander, friend-maker, and ...
(Date:9/19/2014)... PITTSBURGH, PA (PRWEB) September 19, 2014 ... a tissue because of problems with seasonal allergies or ... found a much better alternative. , She conceived ... associated with having a runny nose in public. Since ... tissues, it promotes more sanitary conditions, particularly when cooking ...
Breaking Medicine News(10 mins):Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2
... prevent mom-to-baby transmission, nevirapine could have downside, study finds ... nevirapine -- widely used in developing countries to prevent ... persists in the breast milk and blood of mothers, ... turn, could increase the risk that they and their ...
... Curing Autism to Host Southern California Celebrity Gala, ... and model will co-host a major fundraiser to benefit,families ... France,champion road racing cyclist., McCarthy and Armstrong host ... Regis Monarch Beach Resort in Dana Point, California on,Friday, ...
... Campaign ... of a Loved Dog, DENVER, Aug. 5 Three ... presents. Instead, she asked,friends for donations to honor the Frosts, ... followed in her big sister,s footsteps, and,the two became crusaders ...
... 5 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ), ... manufacturer of the patented anti-cancer biotech,product Endu in China, ... 30, 2008., Highlights -- Total revenue ... second quarter, representing a 30.4% year-over-year ...
... explains the pros, cons of purchasing COBRA to cover healthcare costs ... Security Disability Insurance benefits , ... Belleville, Ill. (Vocus) ... triggers a number of issues for adults who must stop working ...
... emergency service now available for pet owners and first responders in ... leading pet safety company in the Northern Hemisphere, Rover Respond,R™ not ... responders and animal rescue groups and provides peace of mind to ... ...
Cached Medicine News:Health News:HIV Drug Might Spur Resistant Strains of Virus 2Health News:Jenny McCarthy and Lance Armstrong Top Celebrity List to Raise Funds for Autism 2Health News:Photo: Sisters Forgo Birthday Gifts in Effort To Raise Money To Cure Canine Cancer 2Health News:Photo: Sisters Forgo Birthday Gifts in Effort To Raise Money To Cure Canine Cancer 3Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 12Health News:Ten Questions to Ask When Considering COBRA Following a Disability 2Health News:Ten Questions to Ask When Considering COBRA Following a Disability 3Health News:Ten Questions to Ask When Considering COBRA Following a Disability 4Health News:Ten Questions to Ask When Considering COBRA Following a Disability 5Health News:Ten Questions to Ask When Considering COBRA Following a Disability 6Health News:Emergencies Are No Longer Obstacles in Responsible Pet Care 2Health News:Emergencies Are No Longer Obstacles in Responsible Pet Care 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: